1、 1 ()A CBE - - (1) (2) (3) (4) 2 - 3- - 4 ?60g?3-4 30g15g1/24- 620g30g1/2 4- 630g30g1/13- 4 -?- -. - 1 2 3 - - 10% 16% 20 45 1193- 16028%240 3-4567 89101112- 34%50% 10%5 1 - 2 - 3 - 4 5 6 7 B - - 3550% 90% - ?12 1503020 1510 1261201 1-286.8 23010 51 ? - - 1/5 - - ? (1) (2) (3) - (4) ? (1) (2) (3) 39
2、 B B? B - 70%- -? 1.5cm - (Dormia) - - - X ? - - - - -: - - - - 474- 15.4% (1) (2) (3) (4) (5) 1 - - - 1972Danjinger4 2cm X 15mg/g6243070% B1 3 -3 25% Rowacholmetronidazole 1985 - 2-PTC 3 ESWL 1984Lauerbwchextracorporeal shock wave-lithotripsyESWLEDAP LT- 01320 4mm75mm9107PZ 1.252.5/sec100%6075 B 1215mm 31520mm1 19881EDAP-LT 0168798%1 234627%33%40% 45%50%45%16% UDCA8mg/kg /d- 11.2% 4- 5- 6 1 2 3 4 : 1. 2. 3. CT 4. -ERCP 5. -PTC 6. EUS 7. MRCP 8. CT 9. : 1 - 2AC 3- -
